An increased frequency of CHEK2*1100delC was found among breast carcinoma families without BRCA1 or BRCA2 mutations, associated with an approximately two-fold increase of breast cancer risk in female carriers (Meijers-Heijboer et al, 2002). This evidence concerns the gene BRCA2 and breast carcinoma.